MiniMed Connect by Medtronic Receives US FDA Approval
Medtronic has received approval from the US Food and Drug Administration (FDA) for MiniMed Connect, which monitors glucose levels through […]
Medtronic has received approval from the US Food and Drug Administration (FDA) for MiniMed Connect, which monitors glucose levels through […]
Medtronic has joined hands with IBM to develop a new generation of personalised diabetes management solutions. As per the deal […]
Medtronic, Inc. has announced it has received United States Food and Drug Administration (FDA) approval, under a humanitarian device exemption […]
The promoters have so far infused Rs 40 crore in the medical equipment business through equity and have invested another […]
Indian Angel Network (IAN) and India Innovation Fund announced today an undisclosed investment in Consure Medical; a Delhi based company […]
J and J are now focusing on areas like diagnostics and stents for blood vessels outside the heart.
The Care Group of Hospitals owned by Quality CareIndia Limited (QCIL) acquired a five-star hotel premisesat Banjara Hills, Hyderabad, in […]
Global market for Cardiac Defibrillators the market is forecast to exceed USD 16 billion by 2015. The market is primarily driven by the increasing incidence of cardiovascular diseases due to aging population and the increasing availability of emergency medical services worldover for the revival of sudden cardiac death victims.
[This article was published in the September 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Business News
Intel Corp, the world’s biggest computer chip maker, recently won clearance from the US Food and Drug Administration to sell an in-home health monitoring system for patients with chronic conditions.
Medtronic Inc, a US-based global leader in medical technology, recently announced the opening of the first centre of excellence for device implantation in South Asia in collaboration with Care Hospital here. Care Hospital will be the first centre in South Asia to offer hands-on training to cardiologists.
US-based Medtronic, Inc. plans to buy a 15% stake in Shandong Weigao Group Medical Polymer Co., Ltd. for HKD 1.73 billion, or USD 220 million, the two companies jointly announced.